Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

Authors not listed

Baylor College of Medicine · 2022

Abstract

Alzheimer's disease (AD) is associated with significant, progressive cognitive decline. Key defects in mitochondrial fuel metabolism insulin resistance, inflammation and decreased brain glucose uptake are linked to AD. This trial will investigate the effects of supplementing glycine and N-acetylcysteine vs. alanine as placebo on these defects in AD, and examine the effects on cognition.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2022). Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease. <em>Baylor College of Medicine</em>. https://clinicaltrials.gov/study/NCT04740580
Vancouver
Anonymous. Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease. Baylor College of Medicine. 2022.
BibTeX
@misc{anon2022Glutat, title = {Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease}, author = {Anonymous}, journal = {Baylor College of Medicine}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings